Siddarth Chandrasekaran has a diverse background in biomedical engineering, with experience in leading preclinical research teams focused on developing cell therapies for cancer treatment. Siddarth has a strong foundation in immunology and has made significant contributions to the field through their work in various biotech companies. Siddarth is a dedicated and innovative scientist with a track record of successful project development and implementation. Siddarth's impressive academic achievements and research experience demonstrate their commitment to advancing the field of cancer research.
January 1, 2024 - present
January, 2022
August, 2021